1. Home
  2. Analysis
  3. Dimenhydrinate
  4. Prochlorperazine-maleate

Dimenhydrinate and Prochlorperazine maleate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Dimenhydrinate and Prochlorperazine maleate together.

The phase IV clinical study analyzes what interactions people who take Dimenhydrinate and Prochlorperazine maleate have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

5 people who take Dimenhydrinate and Prochlorperazine maleate together, and have interactions are studied.

What is Dimenhydrinate?

Dimenhydrinate has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 4,714 Dimenhydrinate users for its effectiveness, alternative drugs and more.

What is Prochlorperazine maleate?

Prochlorperazine maleate has active ingredients of prochlorperazine maleate. It is often used in nausea. eHealthMe is studying from 8,290 Prochlorperazine maleate users for its effectiveness, alternative drugs and more.

Number of Dimenhydrinate and Prochlorperazine maleate reports submitted per year:

Dimenhydrinate and Prochlorperazine maleate drug interactions.

Common Dimenhydrinate and Prochlorperazine Maleate drug interactions by gender *:

female:

  1. Dyspnoea
  2. Extrapyramidal disorder
  3. Eye movement disorder
  4. Migraine
  5. Musculoskeletal stiffness
  6. Neovascularisation
  7. Paradoxical drug reaction
  8. Swollen tongue
  9. Tachycardia
  10. Torticollis

male:

  1. Acute coronary syndrome
  2. Myocardial infarction

Common Dimenhydrinate and Prochlorperazine Maleate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Dysarthria
  3. Eye movement disorder
  4. Musculoskeletal stiffness
  5. Swollen tongue
  6. Tachycardia
  7. Torticollis
  8. Tremor

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain
  2. Acute coronary syndrome
  3. Neovascularisation
  4. Paradoxical drug reaction
  5. Weight decreased
  6. Anuria
  7. Cough
  8. Diarrhoea
  9. Drug ineffective
  10. Dyspnoea

* Approximation only. Some reports may have incomplete information.

Do you take Dimenhydrinate and Prochlorperazine maleate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Dimenhydrinate and Prochlorperazine maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Dimenhydrinate side effects:

Browse all side effects of Dimenhydrinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prochlorperazine maleate side effects:

Browse all side effects of Prochlorperazine maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Dimenhydrinate interactions:

Browse all interactions between Dimenhydrinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prochlorperazine maleate interactions:

Browse all interactions between Prochlorperazine maleate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dimenhydrinate and prochlorperazine maleate (the active ingredients of Dimenhydrinate and Prochlorperazine maleate, respectively), and Dimenhydrinate and Prochlorperazine maleate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Dimenhydrinate and Prochlorperazine maleate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.